Maurer, Tobias
Eiber, Matthias
Schwaiger, Markus
Gschwend, Jürgen E.
Article History
First Online: 23 February 2016
Competing interests
: T.M. declares a familial association with Celgene<sup>®</sup> (Celgene Corporation, USA); grants or funding from Acelity<sup>®</sup> (KCI Licensing, Inc.), Bayer<sup>®</sup> (Bayer Aktiengesellschaft, Germany) and Takeda Oncology<sup>®</sup> (Takeda Pharmaceutical Company Limited, Japan); consultation for DLR<sup>®</sup> (Deutsches Luft-und Raumfahrtzentrum, Germany) and honoraria from Astellas<sup>®</sup> (Astellas US LLC, USA), Janssen Cilag (Johnson & Johnson, USA) and Sanofi<sup>®</sup> (Sanofi Corporation, France). M.E. declares grants or funding from Bayer<sup>®</sup> and honoraria Astellas<sup>®</sup> and Janssen Cilag. M.S. and J.E.G. declare no competing interests.